SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001664710-21-000048
Filing Date
2021-08-02
Accepted
2021-08-02 09:02:34
Documents
5
Period of Report
2021-07-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K keros-form8xk.htm 8-K 45368
2 EX-99.1 exhibit991cmopr.htm EX-99.1 7525
3 EX-10.1 exhibit101.htm EX-10.1 124883
4 EX-10.2 exhibit102.htm EX-10.2 87183
5 image_0a.jpg GRAPHIC 41482
  Complete submission text file 0001664710-21-000048.txt   323501
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39264 | Film No.: 211134886
SIC: 2834 Pharmaceutical Preparations